These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108 [TBL] [Abstract][Full Text] [Related]
7. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552. Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833 [TBL] [Abstract][Full Text] [Related]
9. Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains. Misra RN; Brown BR; Han WC; Harris DN; Hedberg A; Webb ML; Hall SE J Med Chem; 1991 Sep; 34(9):2882-91. PubMed ID: 1910091 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives. Das J; Vu T; Harris DN; Ogletree ML J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247 [TBL] [Abstract][Full Text] [Related]
11. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists. Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908 [TBL] [Abstract][Full Text] [Related]
12. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles. Ogletree ML; Allen GT J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid. Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Hanasaki K; Kakushi H; Otani K; Hara S J Med Chem; 1988 Sep; 31(9):1847-54. PubMed ID: 2970551 [TBL] [Abstract][Full Text] [Related]
16. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161 [TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity. Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156 [TBL] [Abstract][Full Text] [Related]
19. Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 2. Ohshima E; Takami H; Sato H; Mohri S; Obase H; Miki I; Ishii A; Shirakura S; Karasawa A; Kubo K J Med Chem; 1992 Sep; 35(18):3402-13. PubMed ID: 1388208 [TBL] [Abstract][Full Text] [Related]